Skip to main content

Articles

Page 3 of 20

  1. Premature ovarian insufficiency (POI) is a severe disorder of female infertility, characterized by 4–6 months of amenorrhea before the age of 40 years, with elevated follicle stimulating hormone (FSH) levels (...

    Authors: Lin Li, Fan Feng, Minying Zhao, Tengyan Li, Wentao Yue, Xu Ma, Binbin Wang and Chenghong Yin

    Citation: Journal of Ovarian Research 2020 13:41

    Content type: Research

    Published on:

  2. Our previous studies showed the expression of herpes virus entry mediator (HVEM) is high in ovarian cancer samples and correlated to the patient clinic pathological features. As we all know, the hypoxic enviro...

    Authors: Liyan Duan, Jie Tao, Xiaoqian Yang, Lei Ye, Yueqian Wu, Qizhi He, Yingchun Duan, Li Chen and Jianlong Zhu

    Citation: Journal of Ovarian Research 2020 13:40

    Content type: Research

    Published on:

  3. A recent study published in the journal Nature Communications from Karolinska Institute, Sweden was unable to detect stem cells in adult human ovarian cortex by single-cell RNAseq and by studying cell surface ant...

    Authors: Deepa Bhartiya and Diksha Sharma

    Citation: Journal of Ovarian Research 2020 13:39

    Content type: Brief communication

    Published on:

  4. Ovarian clear cell carcinoma (OCCC) is the second most common ovarian cancer after serous carcinoma in Southeast Asia. OCCC has a more unfavourable clinical outcome due to a poor response to platinum-based che...

    Authors: Huimei Zhou, Qian Liu, Xiaohua Shi, Yue Liu, Dongyan Cao and Jiaxin Yang

    Citation: Journal of Ovarian Research 2020 13:38

    Content type: Research

    Published on:

  5. Although lncRNA CTBP1-AS2 has been functionally analyzed only in cardiomyocyte hypertrophy and diabetes, analysis of TCGA dataset revealed its downregulation in endometrial carcinoma (EC), indicating its invol...

    Authors: Qing-an-zi Wang, Yongxiu Yang and Xiaolei Liang

    Citation: Journal of Ovarian Research 2020 13:37

    Content type: Research

    Published on:

  6. Women with irregular menstruation should be considered to benefit from the ovarian stimulation. However, most literature did not separate ovulatory disorders from normal menstrual cycles. Our purpose was to as...

    Authors: Sichen Li, Yuxia He, Mingzhu Cao, Hanyan Liu and Jianqiao Liu

    Citation: Journal of Ovarian Research 2020 13:36

    Content type: Research

    Published on:

  7. Epithelial ovarian cancer (EOC) is highly lethal gynecological cancer. Forkhead Box Protein C2 (FOXC2) promotes occurrence and development of various malignant tumors. The present study is aimed at exploring t...

    Authors: Zhijiao Zhou, Xiang Ou, Qiong Zou, Ling Chu, Xiyun Quan, Yong Chen and Yang Liu

    Citation: Journal of Ovarian Research 2020 13:34

    Content type: Research

    Published on:

  8. Primary ovarian signet-ring cell carcinoma is extremely rare, with only five recent case reports. Almost all reported cases of ovarian signet-ring cell carcinoma have been treated with TC therapy and none have...

    Authors: Tadahiro Shoji, Ryosuke Takeshita, Tatsunori Saito, Takeshi Aida, Shunichi Sasou and Tsukasa Baba

    Citation: Journal of Ovarian Research 2020 13:33

    Content type: Case report

    Published on:

  9. Polycystic ovary syndrome (PCOS) is a complex reproduction and endocrine disorder of women in the reproductive age. Spearmint (Mentha spicata L.) has anti-androgenic activity and flaxseed (Linum usitatissimum L.)...

    Authors: Mina Mehraban, Gholamali Jelodar and Farhad Rahmanifar

    Citation: Journal of Ovarian Research 2020 13:32

    Content type: Research

    Published on:

  10. As one of the main gynecological cancers, ovarian cancer (OC) has an unfavourable outcomes owing to its high recurrence and metastasis rate. Our previous studies have revealed that LINC01296 functions as an on...

    Authors: Hui Xu, Hong-Luan Mao, Xin-Rui Zhao, Yue Li and Pei-Shu Liu

    Citation: Journal of Ovarian Research 2020 13:31

    Content type: Research

    Published on:

  11. Olaparib, a poly ADP-ribose polymerase (PARP) inhibitor, has proven to be effective and safe as maintenance therapy and multiline therapy in ovarian cancer, especially in patients with BRCA mutations. This stu...

    Authors: Jing Ni, Rui Zhou, Xianzhong Cheng, Xia Xu, Wenwen Guo and Xiaoxiang Chen

    Citation: Journal of Ovarian Research 2020 13:29

    Content type: Case report

    Published on:

  12. The original article [1] contains errors in Fig. 3C, Results and Discussion.

    Authors: Huan Wu, Rongrong Li, Zhiwei Zhang, Huiyang Jiang, Hanlin Ma, Cunzhong Yuan, Chenggong Sun, Yingwei Li and Beihua Kong

    Citation: Journal of Ovarian Research 2020 13:28

    Content type: Correction

    Published on:

    The original article was published in Journal of Ovarian Research 2019 12:125

  13. Ovarian cancer (OC) is usually detected in late clinical stages, and imaging at diagnosis is crucial. Peritoneal carcinomatosis (PC) and cardio phrenic lymph nodes (CPLN) are pathological findings of computed ...

    Authors: Hanna Sartor, Maria Bjurberg, Mihaela Asp, Anna Kahn, Jenny Brändstedt, Päivi Kannisto and Karin Jirström

    Citation: Journal of Ovarian Research 2020 13:26

    Content type: Research

    Published on:

  14. Ovarian hyperstimulation syndrome (OHSS) is a rare, yet severe, iatrogenic complication of ovulation induction therapy during assisted reproductive procedures. Our group previously detected atypical cells in t...

    Authors: Balint Farkas, Ferenc Boldizsar, Noemi Bohonyi, Nelli Farkas, Saska Marczi, Gabor L. Kovacs, Jozsef Bodis and Miklos Koppan

    Citation: Journal of Ovarian Research 2020 13:25

    Content type: Research

    Published on:

  15. Cervical cancer is the fourth-ranked cancer in the world and is associated with a large number of deaths annually. Chemotherapy and radiotherapy are known as the common therapeutic approaches in the treatment ...

    Authors: Shahla Chaichian, Bahram Moazzami, Fatemeh Sadoughi, Hamed Haddad Kashani, Marsa Zaroudi and Zatollah Asemi

    Citation: Journal of Ovarian Research 2020 13:24

    Content type: Review

    Published on:

  16. Women with endometriosis and previous cystectomy may respond less well to gonadotropin stimulation, which results in fewer oocytes retrieved and poor pregnancy outcomes. Choosing an appropriate protocol for su...

    Authors: Feiyan Zhao, Yonglian Lan, Tong Chen, Zhimin Xin, Yu Liang, Ying Li, Shuyu Wang, Jun Zhang and Xiaokui Yang

    Citation: Journal of Ovarian Research 2020 13:23

    Content type: Research

    Published on:

  17. Fragile X premutation (Amplification of CGG number 55–200) is associated with increased risk for fragile X-Associated Premature Ovarian Insufficiency (FXPOI) in females and fragile X-associated tremor/ataxia s...

    Authors: M. Friedman-Gohas, S. E. Elizur, O. Dratviman-Storobinsky, A. Aizer, J. Haas, H. Raanani, R. Orvieto and Y. Cohen

    Citation: Journal of Ovarian Research 2020 13:22

    Content type: Research

    Published on:

  18. Recent studies have suggested that estrogen (E2) plays an important role in epithelial ovarian cancer (EOC). However, the mechanism of E2 in ovarian cancers is unclear. The purpose of this study was to investi...

    Authors: Shengnan Li, Kuo Jiang, Jia Li, Xiaohua Hao, Wenguang Chu, Ceng Luo, Yuanyuan Zhu, Rougang Xie and Biliang Chen

    Citation: Journal of Ovarian Research 2020 13:20

    Content type: Research

    Published on:

  19. The aim of this study was to explore the clinicopathological characteristics of recurrent adult-type granulosa cell tumor of the ovary (AGCOT) and evaluated the treatment results to define the prognostic param...

    Authors: Dan Zhao, Yanan Zhang, Zhengjie Ou, Rong Zhang, Shan Zheng and Bin Li

    Citation: Journal of Ovarian Research 2020 13:19

    Content type: Research

    Published on:

  20. PPOS protocols, initially described for FP in women with cancer, have many advantages compared to antagonist protocols. PPOS protocols were not evaluated for women with endometriosis. The objective of the stud...

    Authors: Emmanuelle Mathieu d’Argent, Clément Ferrier, Chrysoula Zacharopoulou, Naouel Ahdad-Yata, Anne-Sophie Boudy, Adèle Cantalloube, Rachel Levy, Jean-Marie Antoine, Emile Daraï and Sofiane Bendifallah

    Citation: Journal of Ovarian Research 2020 13:18

    Content type: Research

    Published on:

  21. The aim of this study is to establish a noninvasive preoperative model for predicting primary optimal cytoreduction in advanced epithelial ovarian cancer by HE4 and CA125 combined with clinicopathological para...

    Authors: Li-yuan Feng, Sheng-bin Liao and Li Li

    Citation: Journal of Ovarian Research 2020 13:17

    Content type: Research

    Published on:

  22. Cancer stem cells (CSCs) can self-renew, proliferate into differentiated cells, or enter a quiescent state and are regarded to cause chemoresistance and recurrence. An integrative analysis of transcription fac...

    Authors: Hyun Park, Sohyun Hwang, Ju-Yeon Jeong, Sang Geun Jung, Min Chul Choi, Won Duk Joo, Seung Hun Song, Chan Lee and Hee Jung An

    Citation: Journal of Ovarian Research 2020 13:16

    Content type: Research

    Published on:

  23. DCN (decorin) is a proteoglycan known to be involved in regulating cell proliferation, collagen fibril organization and migration. In our global transcriptome RNA-sequencing approach to systematically identify ne...

    Authors: A. Kedem, K. Ulanenko-Shenkar, Y. Yung, G. M. Yerushalmi, E. Maman and A. Hourvitz

    Citation: Journal of Ovarian Research 2020 13:15

    Content type: Research

    Published on:

  24. Bevacizumab and gemcitabine are key drugs for treating recurrent epithelial ovarian cancer. However, information about the combination of bevacizumab and gemcitabine is insufficient. We conducted a phase II st...

    Authors: Shoji Nagao, Ai Kogiku, Kazuhiro Suzuki, Takashi Shibutani, Kasumi Yamamoto, Tomoatsu Jimi, Miho Kitai, Takaya Shiozaki, Kazuko Matsuoka and Satoshi Yamaguchi

    Citation: Journal of Ovarian Research 2020 13:14

    Content type: Research

    Published on:

  25. We elucidated the role of specific MicroRNAs (miRNAs) in the development of polycystic ovary syndrome (PCOS) and explained the changes in the proliferation of granulosa cells. Excised ovarian cortex specimens ...

    Authors: Zhengfang Xiong, Bing Li, Wenjuan Wang, Xianghui Zeng, Binye Li, Shengyan Jian and Liyun Wang

    Citation: Journal of Ovarian Research 2020 13:13

    Content type: Research

    Published on:

  26. Degeneration of ovarian function is an obvious feature of female aging. In addition, studies have shown that autophagy decreases with age, and DNA methylation is a hallmark epigenetic pattern during aging. How...

    Authors: Qiuyuan Li, Minghui Cai, Jiao Wang, Qiang Gao, Xiaocheng Guo, Xiaotong Jia, Shanshan Xu and Hui Zhu

    Citation: Journal of Ovarian Research 2020 13:12

    Content type: Research

    Published on:

  27. Polycystic ovary syndrome (PCOS) is a polygenic endocrine disorder and the most common gynecological endocrinopathy among reproductive-aged women. Current remedies are often used only to control its signs and ...

    Authors: Fatemeh Pourteymour Fard Tabrizi, Fatemeh Hajizadeh-Sharafabad, Maryam Vaezi, Hamed Jafari-Vayghan, Mohammad Alizadeh and Vahid Maleki

    Citation: Journal of Ovarian Research 2020 13:11

    Content type: Review

    Published on:

  28. Ovarian cancer (OC) ranks fifth as a cause of gynecological cancer-associated death globally. Until now, the molecular mechanisms underlying the tumorigenesis and prognosis of OC have not been fully understood...

    Authors: Dan Yang, Yang He, Bo Wu, Yan Deng, Nan Wang, Menglin Li and Yang Liu

    Citation: Journal of Ovarian Research 2020 13:10

    Content type: Research

    Published on:

  29. The limitation of current biomarker of early stage ovarian cancer and the anatomical location of ovarian (depths of the pelvic) make ovarian cancer difficult to be detected in early stage. Growing evidence sho...

    Authors: Lin Cheng, Kun Zhang, Yunan Qing, Dong Li, Manhua Cui, Peng Jin and Tianmin Xu

    Citation: Journal of Ovarian Research 2020 13:9

    Content type: Research

    Published on:

  30. With the improvement of bacterial detection, the theory of the sterile female upper reproductive tract has been frequently challenged in recent years. However, thus far, no researchers have used ovaries as stu...

    Authors: Qi Wang, Lanbo Zhao, Lu Han, Guoxing Fu, Xiaoqian Tuo, Sijia Ma, Qing Li, Yiran Wang, Dongxin Liang, Miaomiao Tang, Chao Sun, Qing Wang, Qing Song and Qiling Li

    Citation: Journal of Ovarian Research 2020 13:8

    Content type: Research

    Published on:

  31. The timing of the first postpartum ovulation is an important factor affecting the timing of estrous resumption in dairy cows. The first postpartum ovulation is delayed in cows producing large amounts of milk w...

    Authors: Eri Furukawa, Tomoyuki Masaki, Kenichiro Sakaguchi, Min Bo, Yojiro Yanagawa, Koichiro Ueda and Masashi Nagano

    Citation: Journal of Ovarian Research 2020 13:7

    Content type: Research

    Published on:

  32. To evaluate the diagnostic performance of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) for ovarian cancer.

    Authors: Kexin Li, Yuqing Pei, Yue Wu, Yi Guo and Wei Cui

    Citation: Journal of Ovarian Research 2020 13:6

    Content type: Review

    Published on:

  33. The complex regulatory mechanism involved in ovarian follicular development is not completely understood. Neuronal neuropeptide Y (NPY) is involved in the regulation of feeding behavior, energy homeostasis, an...

    Authors: Yoko Urata, Reza Salehi, Patricia D. A. Lima, Yutaka Osuga and Benjamin K. Tsang

    Citation: Journal of Ovarian Research 2020 13:5

    Content type: Research

    Published on:

  34. Lipids are an important source for energy production during oocyte maturation. The accumulation of intracellular lipids binds to proteins to form lipid droplets. This may lead to cellular lipotoxicity. The imp...

    Authors: Shira Raviv, Shay Hantisteanu, Shilhav Meisel Sharon, Yuval Atzmon, Mediea Michaeli and Einat Shalom-Paz

    Citation: Journal of Ovarian Research 2020 13:4

    Content type: Research

    Published on:

  35. The role of lncRNA miR503HG has been investigated in several types of cancer, but its functions in ovarian cancer (OC) is unclear. Analysis of TCGA dataset revealed a 50-fold lower expression level of miR503HG...

    Authors: Ding Zhu, Xueshuang Huang, Fang Liang and Lijing Zhao

    Citation: Journal of Ovarian Research 2020 13:3

    Content type: Research

    Published on:

  36. Acute myeloid leukemia (AML) in monozygotic twins is a rare event and, until now, only a few cases have been reported. Due to improved oncological treatment and cancer survival rates, quality of life considera...

    Authors: Tanja Burnik Papler, Eda Vrtacnik Bokal and Nina Jančar

    Citation: Journal of Ovarian Research 2020 13:2

    Content type: Case report

    Published on:

  37. Secondary cytoreductive surgery (SCS) is possible in selected patients with recurrent epithelial ovarian cancer (EOC). The goal of SCS is complete resection, although chemotherapy is always followed. Delayed i...

    Authors: Soo Young Jeong, Chel Hun Choi, Tae Joong Kim, Jeong Won Lee, Byoung-Gie Kim, Duk Soo Bae and Yoo-Young Lee

    Citation: Journal of Ovarian Research 2019 13:1

    Content type: Research

    Published on:

  38. Ovarian cancer is the most lethal gynaecologic malignancy. Although there are various subtypes of ovarian cancer, high-grade serous ovarian cancer (HGSOC) accounts for 70% of ovarian cancer deaths. Chemoresist...

    Authors: Huan Wu, Rongrong Li, Zhiwei Zhang, Huiyang Jiang, Hanlin Ma, Cunzhong Yuan, Chenggong Sun, Yingwei Li and Beihua Kong

    Citation: Journal of Ovarian Research 2019 12:125

    Content type: Research

    Published on:

    The Correction to this article has been published in Journal of Ovarian Research 2020 13:28

  39. Alpha-fetoprotein (AFP) plays a crucial role in the management of malignant ovarian germ cell tumors (MOGCTs) and is an important reference index for chemotherapy termination. However, a high level of AFP can ...

    Authors: Xuan Zong, Jia-Xin Yang and Ying Zhang

    Citation: Journal of Ovarian Research 2019 12:124

    Content type: Case report

    Published on:

  40. Endometriosis is considered to be the most intractable cause of female infertility. Administering any type of treatment for endometriosis before in vitro fertilization and embryo transfer (IVF-ET) is an import...

    Authors: Hiroshi Tamura, Hiroaki Yoshida, Hiroyuki Kikuchi, Mai Josaki, Yumiko Mihara, Yuichro Shirafuta, Masahiro Shinagawa, Isao Tamura, Toshiaki Taketani, Akihisa Takasaki and Norihiro Sugino

    Citation: Journal of Ovarian Research 2019 12:123

    Content type: Research

    Published on:

  41. Epithelial ovarian cancer (EOC) is the deadliest female malignancy. The Wnt/β-catenin pathway plays critical roles in regulating embryonic development and physiological processes. This pathway is tightly regul...

    Authors: Vu Hong Loan Nguyen, Rebecca Hough, Stefanie Bernaudo and Chun Peng

    Citation: Journal of Ovarian Research 2019 12:122

    Content type: Review

    Published on:

  42. Increasing researches have demonstrated the critical functions of MicroRNAs (miRNAs) in the progression of malignant tumors, including ovarian cancer. It was reported that miR-552 was an important oncogene in ...

    Authors: Wenman Zhao, Tao Han, Bao Li, Qianyun Ma, Pinghua Yang and Hengyu Li

    Citation: Journal of Ovarian Research 2019 12:121

    Content type: Research

    Published on:

  43. Ovarian cancer has the highest ratio of mortality among gynecologic malignancies. Chemotherapy is one of the most common treatment options for ovarian cancer. However, tumor relapse in patients with advanced t...

    Authors: Vahideh Keyvani, Moein Farshchian, Seyed-Alireza Esmaeili, Hadi Yari, Meysam Moghbeli, Seyed-Reza Kazemi Nezhad and Mohammad Reza Abbaszadegan

    Citation: Journal of Ovarian Research 2019 12:120

    Content type: Review

    Published on:

  44. Ovarian cancer (OC) is a type of gynaecological malignancy with high mortality in females. Serous ovarian cancer (SOC) is a distinct subtype of OC with poor early diagnosis. Given the limitations of traditiona...

    Authors: Zhi-Ying Qi, Fang Wang, Ying-Ying Yue, Xue-Wang Guo, Rui-Meng Guo, Hong-Lin Li and Yan-Ying Xu

    Citation: Journal of Ovarian Research 2019 12:118

    Content type: Research

    Published on:

  45. Poly (ADP-ribose) polymerase (PARP) inhibitor, is a milestone in treatment of ovarian cancer. However, there is no real world study from China regarding the clinical outcome of the taking PARP inhibitor (PARPi...

    Authors: Jing Ni, Xianzhong Cheng, Rui Zhou, Xia Xu, Wenwen Guo and Xiaoxiang Chen

    Citation: Journal of Ovarian Research 2019 12:117

    Content type: Research

    Published on:

Annual Journal Metrics